The aim of this observational, descriptive study is to evaluate the impact of an intensive, evidence-based preventive cardiology programme on medical and lifestyle risk factors in patients at high risk of developing cardiovascular disease (CVD).
Methods
Increased CVD risk patients and their family members/partners were invited to attend a 16-week programme consisting of a professional multidisciplinary lifestyle intervention, with appropriate risk factor and therapeutic management in a community setting. Smoking, dietary habits, physical activity levels, waist circumference and body mass index, and medical risk factors were measured at initial assessment, at end of programme, and at 1-year follow up.
Results
Adherence to the programme was high, with 375 (87.2%) participants and 181 (84.6%) partners having completed the programme, with 1-year data being obtained from 235 (93.6%) patients and 107 (90.7%) partners. There were statistically significant improvements in both lifestyle (body mass index, waist circumference, physical activity, Mediterranean diet score, fish, fruit, and vegetable consumption, smoking cessation rates), psychosocial (anxiety and depression scales and quality of life indices), and medical risk factors (blood pressure, lipid and glycaemic targets) between baseline and end of programme, with these improvements being sustained at 1-year follow up.
Conclusions
These findings demonstrate how a holistic model of CVD prevention can improve cardiovascular risk factors by achieving healthier lifestyles and optimal medical management.
World Health Organization. World health statistics 2012, France: WHO, 2012.
2.
AllenderSSPPetoV. European cardiovascular disease statistics, 2008 edition, London: British Heart Foundation, 2008.
3.
Central Statistics Office. Annual report on vital statistics. Dublin: Central Statistics Office, 2009.
4.
Children DoHa. Changing cardiovascular health: national cardiovascular health policy 2010–2019. Dublin: Government Publications, 2010.
5.
BerraKMillerNHJenningsC. Nurse-based models for cardiovascular disease prevention: from research to clinical practice. Eur J Cardiovasc Nurs2011; 10(suppl. 2): S42–S50.
6.
YusufPSHaweekenSÔunpuuS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet2004; 364: 937–952.
7.
RoseG. Strategy of prevention: lessons from cardiovascular disease. BMJ1981; 282: 1847–1851.
8.
ManuelDGLimJTanuseputroP. Preventive medicine – revisiting rose: strategies for reducing coronary heart disease. BMJ2006; 332: 659–662.
9.
Tunstall-PedoeHKuulasmaaKMähönenM. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet1999; 353: 1547–1557.
10.
FordESAjaniUACroftJB. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Eng J Med2007; 356: 2388–2398.
11.
BennettKKabirZUnalB. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985–2000. J Epidemiol Community Health2006; 60: 322–327.
12.
Brugha R, Tully N, Dicker P, Shelley E, Ward M and McGee H. SLÁN 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland. Smoking Patterns in Ireland: Implications for policy and services. Department of Health and Children. Dublin: The Stationery Office, 2009.
13.
KotsevaKWoodDDe BackerG. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: Cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil2010; 17: 530–540.
14.
Perk J, De Backer G, Gohlke H, et al.; Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice; European Association for Cardiovascular Prevention and Rehabilitation. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012; 223: 1–68.
15.
VolpeMTocciG. Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trial. Aging Clin Exp Res2005; 17(4 Suppl): 46–53.
16.
SeverPS. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?Am J Med2005; 118(12 Suppl.): 3S–9S.
17.
KjelsbergMO. Mortality after 10 1/2 years for hypertensive participants in the multiple risk factor intervention trial. Circulation1990; 82: 1616–1628.
18.
WoodDKotsevaKConnollyS. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet2008; 371: 1999–2012.
19.
ConnollySHoldenATurnerE. MyAction: An innovative approach to the prevention of cardiovascular disease in the community. Br J Cardiol2011; 18: 171–176.
20.
Gibson I. Heart Smart – a two year report on a community based cardiovascular disease prevention programme in the west of Ireland. Galway: Croi. Available at: www.croi.ie (2008, consulted July 2012).
21.
William MillerSR. Motivational interviewing, London: Guilford, 2002.
22.
ProchaskaJODiClementeCC. Self change processes, self efficacy and decisional balance across five stages of smoking cessation. Progress Clin Biol Res1984; 156: 131–140.
23.
FagerstromKOSchneiderNG. Measuring nicotine dependance: ar eview of the Fagerstrom Tolerance Questionaire. J Behav Med1989; 12: 159–182.
24.
EstruchRMartínez-GonzálezMACorellaD. Effects of a mediterranean-style diet on cardiovascular risk factors a randomized trial. Ann Intern Med2006; 145: 1–11.
25.
BlaireSNHaskellWLHoP. Assessment of habitual physical activity by a seven day recall in a community survey and controlled experiments. Am J Epidemol1985; 122: 794–804.
26.
SkyesK. Chester step test; resource pack version 3, Cheshire, UK: Chester College of Higher Education, 1998.
27.
SnaithRP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes2003; 1: 29–29.
28.
Rosalind Rabin MO and Mark Oppe. EQ-5D-3L: user guide. Basic information on how to use the EQ-5D-3L instrument, version 4.0. EUROQoL Group; 2011.
29.
BentsenBGNatvigBWinnemM. Questions you didn't ask? COOP/WONCA charts in clinical work and research. Fam Pract1999; 16: 190–195.
30.
RydénLStandlEMałgorzataB. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J2007; 28: 88–136.
31.
Joint British Societies. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart2009; 91(Suppl. 5): v1–v52.
32.
TaylorLMSpenceJCRaineK. Physical activity and health-related quality of life in individuals with prediabetes. Diabetes Res Clin Pract2010; 90: 15–21.
33.
AnandacoomarasamyACatersonIDLeibmanS. Influence of BMI on health-related quality of life: comparison between an obese adult cohort and age-matched population norms. Obesity2009; 17: 2114–2118.
34.
WilliamsonDARejeskiJLangW. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med2009; 169: 163–171.
35.
VasiljevicNRalevicSKolotkinRL. The relationship between weight loss and health-related quality of life in a Serbian population. Eur Eating Disord Rev2012; 20: 162–168.
36.
CostarelliVKoretsiEGeorgitsogianniE. Health-related quality of life of Greek adolescents: the role of the Mediterranean diet. Qual Life Res2012; 22: 951–956.
37.
LeeCRussellA. Effects of physical activity on emotional well-being among older Australian women cross-sectional and longitudinal analyses. J Psychosom Res2003; 54: 155–160.
38.
StaniuteMBrozaitieneJBuneviciusR. Effects of social support and stressful life events on health-related quality of life in coronary artery disease patients. J Cardiovasc Nurs2013; 28: 83–89.
39.
Eilat-AdarSEldarMGoldbourtU. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol2005; 161: 352–358.
40.
MyersJPrakashMFroelicherV. Exercise capacity and mortality among men referred for exercise testing. N Eng J Med2002; 346: 793–801.
41.
GulatiMPandeyDKArnsdorfMF. Exercise capacity and the risk of death in women: the St. James Women Take Heart Project. Circulation2003; 108: 1554–1559.
42.
SofiFCesariFAbbateR. Adherence to Mediterranean diet and health status: meta-analysis. BMJ2008; 337: 673–675.
43.
EstruchRRosESalas-SalvadóJ. Primary prevention of cardiovascular disease with a Mediterranean diet. N Eng J Med2013; 368: 1279–1290.
44.
BerraK. Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?J Cardiovasc Nurs2011; 26: 145–167.
45.
WoodDARobertsTLCampbellM. Women married to men with myocardial infarction are at increased risk of coronary heart disease. J Cardiovasc Risk1997; 4: 7–11.
46.
PykeSDMWoodDAKinmonthAL. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention: the British Family Heart study. Arch Fam Med1997; 6: 354–360.
47.
BerraKMillerNHFairJM. Cardiovascular disease prevention and disease management: a critical role for nursing. J Cardiopulm Rehabil2006; 26: 197–206.
48.
Shortall R. Reform of primary care, 2012–2015. In: Children DoHa, editor, Changing cardiovascular health: national cardiovascular health policy 2010–2019 2010. 2012.
